You are Trying to View a Free Article

Botox King Allergan Plumps up Beauty Biz with $2.5 Billion Zeltiq Fat Buster Buy


Industry Segment: Pharmaceutical & Biotech | Word Count: 302 Words

SUGAR LAND--February 15, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Allergan plc (NYSE:AGN) (Dublin, Ireland) continues its buying spree with the $2.5 billion bid for Zeltiq Aesthetics (NASDAQ: ZLTQ) (Pleasanton, California). Why Zeltiq? The company complements Allergan's medical aesthetic portfolio, as its lead product is the CoolSculpting System, an FDA-cleared system that reduces unwanted fat. Using patented cooling technology, it is a non-invasive alternative to liposuction.

Login or Register for Instant Access

Subscribe Now! All Fields Required...

Standard Membership - Free

All Members Receive the Following Free Resources:

  • North American Project & Gap Spending
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current Economic Indicators
  • Free Daily Industrial Articles
  • Monthly Industrial Newsletter